Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Total and high-molecular-weight adiponectin levels and prediction of insulin resistance

D. Horakova, L. Stepanek, R. Nagelova, D. Pastucha, K. Azeem, H. Kollarova,

. 2018 ; 69 (4) : 375-380. [pub] 20180628

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012583

INTRODUCTION: Adiponectin is a peptide secreted by adipocytes; its reduction is associated with obesity-related disorders, including insulin resistance (IR). The study analysed levels of total adiponectin and its high-molecular-weight (HMW) oligomer in a group of metabolically healthy adults and in patients with type 2 diabetes mellitus (T2DM) to evaluate these levels as potential predictors of the presence of IR. MATERIALS AND METHODS: The study comprised 269 metabolically healthy adults and 300 patients with T2DM. Anthropometric and bio-chemical indices were measured, including total and HMW adiponectin levels; the Homeostatic Model Assessment of IR (HOMA-IR) index was calculated, and logistic regression analysis was used to predict the presence of IR. RESULTS: In healthy individuals, both total and HMW adiponectin levels were significantly higher than in diabetic patients. Total and HMW adiponectin levels were moderately correlated with the HOMA-IR index. Logistic regression analysis showed that increased levels of both total adiponectin (odds ratio [OR] 0.598, 95% confidence interval [CI] 0.483-0.723) and the HMW form (OR 0.360, 95% CI 0.242-0.511) are protective factors for the development of IR. The cut-off levels were 4.22 mg/L for total adiponectin and 2.75 mg/L for HMW adiponectin. The results are valid for middle-aged European adults. CONCLUSIONS: Adiponectin levels below the indicated cut-offs may predict a potential risk for the development of IR.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012583
003      
CZ-PrNML
005      
20190411105019.0
007      
ta
008      
190405s2018 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5603/EP.a2018.0035 $2 doi
035    __
$a (PubMed)29952412
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Horakova, Dagmar
245    10
$a Total and high-molecular-weight adiponectin levels and prediction of insulin resistance / $c D. Horakova, L. Stepanek, R. Nagelova, D. Pastucha, K. Azeem, H. Kollarova,
520    9_
$a INTRODUCTION: Adiponectin is a peptide secreted by adipocytes; its reduction is associated with obesity-related disorders, including insulin resistance (IR). The study analysed levels of total adiponectin and its high-molecular-weight (HMW) oligomer in a group of metabolically healthy adults and in patients with type 2 diabetes mellitus (T2DM) to evaluate these levels as potential predictors of the presence of IR. MATERIALS AND METHODS: The study comprised 269 metabolically healthy adults and 300 patients with T2DM. Anthropometric and bio-chemical indices were measured, including total and HMW adiponectin levels; the Homeostatic Model Assessment of IR (HOMA-IR) index was calculated, and logistic regression analysis was used to predict the presence of IR. RESULTS: In healthy individuals, both total and HMW adiponectin levels were significantly higher than in diabetic patients. Total and HMW adiponectin levels were moderately correlated with the HOMA-IR index. Logistic regression analysis showed that increased levels of both total adiponectin (odds ratio [OR] 0.598, 95% confidence interval [CI] 0.483-0.723) and the HMW form (OR 0.360, 95% CI 0.242-0.511) are protective factors for the development of IR. The cut-off levels were 4.22 mg/L for total adiponectin and 2.75 mg/L for HMW adiponectin. The results are valid for middle-aged European adults. CONCLUSIONS: Adiponectin levels below the indicated cut-offs may predict a potential risk for the development of IR.
650    _2
$a adiponektin $x krev $7 D052242
650    _2
$a senioři $7 D000368
650    _2
$a diabetes mellitus 2. typu $x krev $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a molekulová hmotnost $7 D008970
650    _2
$a prognóza $7 D011379
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stepanek, Ladislav $u Department of Preventive Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic. ladislav.stepanek01@upol.cz.
700    1_
$a Nagelova, Radka
700    1_
$a Pastucha, Dalibor
700    1_
$a Azeem, Katerina
700    1_
$a Kollarova, Helena
773    0_
$w MED00001527 $t Endokrynologia Polska $x 2299-8306 $g Roč. 69, č. 4 (2018), s. 375-380
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29952412 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411105036 $b ABA008
999    __
$a ok $b bmc $g 1391893 $s 1050888
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 69 $c 4 $d 375-380 $e 20180628 $i 2299-8306 $m Endokrynologia Polska $n Endokrynol Pol $x MED00001527
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...